Analysis and Description of Neurofibromatosis Type One

Type 1 neurofibromatosis (NF1) is the most common inherited disorder in the world, with a rate of 1 in 3,000 to 4,000 neonates worldwide (Children's Oncology Foundation, 2014) . There are three different types of neurofibromatosis. Neurofibromatosis is the most severe, followed by neurofibromatosis type 2 (NF 2), and finally the most severe neurofibromatosis type 1. Depending on the severity of NF1, one can send a perfectly normal life, complications of debilitating life are still possible and treatment may be time consuming.

Neurofibromatosis is an illness that affects the body's chromosome. It is an inherited disorder affecting the nervous system. The term neurofibromatosis actually refers to two different genetic diseases. The most common type is NF 1, the less common type is NF. Both are autosomal dominant and prevalent. Autosomal dominant diseases are single autosomal dominant genes; diseases caused by the presence of abnormal factors located on chromosomes other than sex chromosomes. They are characterized by the occurrence of multiple neurofibroma

Common diseases such as diabetes and heart disease cause widespread concern and treatment, but most people have rare illness (thought, ataxia - telangiectasia, metachromatic leukodystrophy or type 2 Neurofibromatosis) is a daily serious problem for an estimated 30 million Americans. They wait for treatment or treatment - and as with the drug test and approval process itself - the delay time can be long and dangerous. Recursion Pharmaceuticals is not waiting. The company combines deep learning, computer vision, and robotic automation to generate and analyze microscopic images of millions of individual somatic cells per week. With each image accurately measuring thousands of cells and intracellular features, you can recursively understand the appearance of affected cells, the difference from healthy cells, and the response when treated with different compounds. Compounds that make diseased cells look like healthy cells can be potential therapeutics

DCVC Accelerates Drug Discovery by Investing $ 60 Million in Series B in Recursion Pharmaceuticals: Machine Vision and Robotics

The surrounding crowd spent processing Onno DNA data on weekends. They are looking for genetic clues to cure his type 2 neurofibromatosis, ie NF 2 -. This is a rare illness heard in his left ear. Growth is slow in the middle. Eventually, they can eliminate the hearing, vision and walking abilities remaining in him. This Hackasson is the first public event he tries to use modern computing power to do his own medical research. It also proves the greatest idea in today's medical community, a combination of computer technology and biology to solve the disease code. As genomic sequencing became cheaper and more accessible, the computer became powerful enough to analyze the vast amount of data revealed by such sequencing. Understanding the behavior of specific diseases is becoming a very complex pattern recognition problem.